FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

675 letters match. Newest first.

  1. Milo’s Poultry Farms, LLC

    FDA warns Milo’s Poultry Farms after Salmonella Enteritidis matched outbreak strain in shell eggs and facility.

    High risk
  2. One Roof LLC

    FDA warned One Roof LLC of allergen, pathogen and manufacturing-rule violations in its Baltimore ready-to-eat bakery products.

    High risk
  3. CTK OTC Laboratories LLC formerly FMK LABS, Inc.

    CTK OTC Laboratories, formerly FMK Labs, failed to investigate out-of-spec results and validate processes for OTC drugs, including sunscreens.

    High risk
  4. Evi Labs LLC

    FDA warns Evi Labs over OTC drug manufacturing failures, including an antiperspirant lot above the aluminum chlorohydrate limit.

    High risk
  5. DFI Co., Ltd.

    DFI Co., Ltd. of Gimhae, Korea, made CYBOW 11 urinalysis reagent strips under conditions FDA calls adulterated — complaint, nonconforming product, labeling and MDR failures.

    High risk
  6. Anti L’Age

    FDA warned Anti L'Age over dietary supplements made without required manufacturing standards, records, quality controls, and proper labeling.

    Medium
  7. La Milagrosa 1 LLC

    FDA says La Milagrosa 1 LLC made ready-to-eat Latin-style cheese without a food safety plan and under insanitary conditions.

    High risk
  8. Latro Inc.

    Latro Inc. sells a Delta-8 THC food, Dozo D9 Smashers Peach Mango, that FDA calls adulterated because Delta-8 THC is an unsafe food additive.

    High risk
  9. Jack & The Green Sprouts, Inc.

    FDA warns Jack & The Green Sprouts after sprout samples tested positive for Listeria and inspection found insanitary conditions.

    High risk
  10. United King Foods Private Limited

    FDA warned United King Foods over serious low-acid canned food processing violations for Gulab Jamun exported to the U.S.

    High risk
  11. AACE Pharmaceuticals, Inc.

    AACE Pharmaceuticals distributed adulterated Lubricant PM Ointment made by CMO Brassica with CGMP violations and failed supplier qualification.

    High risk
  12. Shenzhen Hengkaifeng Commerce and Trade Co., Ltd

    Shenzhen Hengkaifeng's Sensitivity Toothpastes listing was inaccurate, making the drug misbranded, FDA says.

    Low
  13. Wailea Agricultural Group, Inc.

    Wailea Agricultural Group's hearts of palm were adulterated after FDA found E. coli in water used for handwashing and cleaning.

    High risk
  14. DRG Instruments GmbH

    FDA warns DRG Instruments over unapproved salivary cortisol ELISA devices and quality system and reporting violations.

    High risk
  15. Reunipeche SAS

    Reunipeche SAS's seafood safety plan (HACCP) for whole fresh fish lacks adequate hazard controls and monitoring, FDA says.

    High risk
  16. Golden Grains Bakery

    FDA warns Golden Grains Bakery over repeated preventive-control failures for RTE Blender Bombs, including metal detection and Listeria risks.

    High risk
  17. Kabe Labortechnik GmbH

    Kabe Labortechnik lacked validated processes and design controls for SAFE-T-FILL blood collection tubes, FDA found.

    High risk
  18. Baldwin Richardson Foods Pennsauken, LLC

    FDA warned Baldwin Richardson Foods Pennsauken of serious low-acid canned food violations after finding microbial growth and process-control failures in aseptic non-dairy beverages.

    High risk
  19. NeuroSync, Inc.

    FDA warned NeuroSync, Inc. that its EYE-SYNC eye-assessment device was adulterated by design control, CAPA, supplier and acceptance failures, plus unreported correction and missing UDI.

    High risk
  20. Microspecialties, LLC

    FDA warned Microspecialties, a Connecticut contract device maker, after it shipped unsterilized eye-surgery injection kits labeled sterile.

    High risk
  21. Gluten Free Remedies LLC

    FDA warns Gluten Free Remedies that Sulbutiamine Plus Brain Support is misbranded because sulbutiamine is not a dietary ingredient.

    Low
  22. NWL Netherlands Services B.V.

    FDA cites NWL Netherlands drug plant for inadequate microbial investigations, missing component identity testing, and weak lab data controls.

    High risk
  23. Breadbox Co.

    Breadbox Co. made ready-to-eat bakery products under insanitary conditions without a required food safety plan, FDA says.

    High risk
  24. Yeshua Bendito, C.A.

    FDA says Yeshua Bendito's Venezuelan RTE crab meat in reduced oxygen packaging is adulterated due to serious seafood HACCP violations.

    High risk
  25. Chongqing Tianrun Food Development Co., Ltd

    Chongqing Tianrun Food Development shipped low-acid canned tofu to the U.S. without required canning registration and filed processes.

    High risk
  26. Dalai Biotech Company Ltd

    FDA says Taiwan’s Dalai Biotech shipped acidified popping boba pearls to the U.S. without required registration or filed scheduled processes.

    High risk
  27. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk
  28. Mentha & Allied Products Private Ltd.

    FDA warns Mentha & Allied Products of CGMP failures that leave its APIs adulterated.

    High risk
  29. Shantou S.E.Z. Baojie Industry Co., Ltd.

    FDA warns Shantou S.E.Z. Baojie Industry over inadequate CGMP and component testing for OTC drug products, leading to Import Alert 66-40.

    High risk
  30. BioAsia Worldwide Sdn Bhd

    FDA warned BioAsia Worldwide over current good manufacturing practice violations for OTC drugs.

    High risk
  31. Nana Barseghian, M.D.

    FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.

    High risk
  32. Dyno Manufacturing, Inc.

    Dyno Manufacturing’s OTC hand sanitizer and antibacterial soap drugs lacked raw-material identity testing and other required manufacturing controls.

    High risk
  33. BEO Pharma Inc. dba BEO Pharmaceuticals Inc.

    FDA cited BEO Pharma for manufacturing quality violations, including missing identity testing of high-risk drug ingredients and releasing a batch before microbial testing.

    High risk
  34. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.

    High risk
  35. Noah Medical Corporation

    FDA warns Noah Medical of San Jose, CA over quality system failures and missed injury reports for its Galaxy bronchoscopes.

    High risk
  36. Nubratori, Inc. dba Nubratori Rx

    FDA cited Nubratori Rx, a sterile compounding outsourcing facility, for insanitary conditions and manufacturing quality failures that may contaminate its drug products.

    High risk
  37. EpiCare Acquisitions, LLC

    FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.

    High risk
  38. Next Science LLC

    FDA warns Next Science that wound gels and irrigation solutions are adulterated and misbranded for uncleared claims and quality failures.

    High risk
  39. Americo F. Padilla, M.D.

    FDA warns clinical investigator Americo F. Padilla, M.D. over failing to obtain parental consent before enrolling pediatric subjects in drug trials.

    High risk
  40. Aspen Biopharma Labs Private Limited

    FDA warns Aspen Biopharma Labs over current good manufacturing practice failures in active ingredient manufacturing after U.S. recall.

    High risk
  41. International Laboratories Corp

    FDA warned International Laboratories Corp, a Thai drug manufacturer, over fabricated lab records and inadequate CGMP controls.

    High risk
  42. Mehran Michael Bahrami, M.D.

    FDA warns clinical investigator Dr. Mehran Michael Bahrami over protocol violations and missing records in investigational drug trials.

    High risk
  43. Aspen Pharmacare Holdings Limited

    FDA warns Aspen subsidiary over sterile OTC drug manufacturing failures including impurity testing, aseptic practices, data integrity, and environmental monitoring.

    High risk
  44. Red Oak Instruments, LLC

    Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.

    High risk
  45. Shree Jaya Laboratories PVT. LTD.

    FDA warned Shree Jaya Laboratories after an inspection found CGMP deviations in API and intermediate manufacturing, including dirty equipment and torn batch records.

    High risk
  46. Linghai ZhanWang Biotechnology Co., Ltd

    Linghai ZhanWang Biotechnology's OTC drugs, including antimicrobial wipes, fail manufacturing quality rules; FDA cites missing tests.

    High risk
  47. Q’Apel Medical, Inc.

    Q’Apel Medical marketed an uncleared modified HIPPO stroke aspiration device and had quality system violations, FDA says.

    High risk
  48. Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals

    FDA warned outsourcing facility Carie Boyd Pharmaceuticals in Irving, TX that sterile drug production had airflow, media fill and contamination control failures.

    High risk
  49. ProRx, LLC

    FDA warns ProRx, LLC about insanitary sterile compounded-drug production and manufacturing-quality failures.

    High risk
  50. Chem-Tech, Ltd.

    Chem-Tech, Ltd. lacked adequate investigations and clean equipment for its OTC drug.

    High risk